From our current issue, this REVIEW describes the mechanisms of mucosal healing and how they might be altered in
#IBD
and discusses potential therapeutic approaches to promote mucosal healing and regeneration
NEW! This Figure shows an overview of glucose metabolic pathways in the hepatocyte.
Find out more about hepatic glucose metabolism in the steatotic liver here
#NAFLD
#MASLD
It's
#WorldMicrobiomeDay
today and this year the theme is diversity. There is certainly a diverse
#microbiota
in our guts, which can be influenced by food.
Read more in this REVIEW ->
Fermented foods have gained popularity owing to their health-promoting potential - this REVIEW discusses the benefits of
#fermentedfoods
in gut health and disease, and how specific microbes, food components and bioactive compounds exert their effects
NEW! This REVIEW explores the mechanisms of mucosal healing and its potential in treating inflammatory bowel disease without immunosuppression
#IBD
#Crohns
#Colitis
No.7 in our top10 articles that grabbed your attention (according to Altmetrics) - this REVIEW on gut
#microbiota
metabolites as key actors in inflammatory bowel disease
#IBD
Best of 2021 - ALTMETRICS
no.5 is this REVIEW on Dietary carbohydrates and fats in nonalcoholic fatty liver disease
By Yki-Jarvinen, Luukkonen, Hodson &
@TheMooreLab
Read-only link
#MAFLD
#NAFLD
#fattyliver
#MASLD
(
#NAFLD
) & alcohol-related liver disease share pathophysiological features and are leading causes of chronic liver disease worldwide
Find out more about their intersection & management in this REVIEW
#WorldLiverDay
NEW online! Nonalcoholic
#fattyliver
disease (
#NAFLD
) has become the most common form of chronic liver disease in children and adolescents. This REVIEW discusses the latest knowledge of epidemiology, pathogenesis & management
#obesity
📢Out now! This new Consensus Statement on Advancing the global public health agenda for
#NAFLD
FREE
Led by
@JVLazarus
& an international list of experts, the article aims to put NAFLD in the NCD spotlight
@EASL_ilf
#fattyliver
#MAFLD
REVIEW | Utilizing the gut
#microbiome
in decompensated
#cirrhosis
and acute-on-chronic liver failure
This Figure summarises strategies to target the gut
#microbiota
in cirrhosis
NEW COMMENT arguing that now is the time tor re-examine the definition of
#NAFLD
- the vast majority of those with NAFLD do not develop clinically significant liver disease & the most frequent individual cause of death in those with NAFLD is
#cardiovasculardisease
Our OCTOBER FOCUS ISSUE ON LIVER FIBROSIS is live! Liver inflammation and cellular stress in fibrosis, HSCs and liver cancer, antifibrotic therapeutic strategies, and much more!
#livertwitter
#livercancer
AUGUST ISSUE | REVIEW
Attaining mucosal healing without immunosuppression is an attractive option for the treatment of
#IBD
. This Review describes the mechanisms of mucosal healing and how they might be altered in IBD
New Review online ICYMI | Here, the authors summarize therapies for the treatment of malignant
#liver
tumours, focusing on surgical & ablative approaches & how they align with therapies such as anticancer drugs or radiotherapy. Find it here:
#LiverCancer
ILC3s orchestrate tissue physiology and immune tolerance in the gut
Check out this new REVIEW on group 3 innate lymphoid cells in intestinal health and disease
Long-term adverse events of proton-pump inhibitors being debated at
#UEGweek
#UEGW2019
- Savarino (myth) vs Fass (reality). The evidence on complications & PPIs was discussed in this review from 2017
GUT–BRAIN AXIS IN 2020 | Diego Bohorquez discusses
#GutBrain
biology in 2020 & how 3 remarkable studies have expanded our knowledge on how the
#gut
makes sense of its environment to guide brain functions & behaviors beyond food
#YearInReview
@gutbrains
From our April issue, this REVIEW discusses the pathophysiology of gastro-oesophageal reflux disease and the implications for diagnosis and management, different GERD phenotypes have different degrees of reflux & severity of symptoms
#GORD
#GERD
#reflux
Primary biliary cholangitis (PBC) is a chronic, inflammatory & cholestatic liver disease with a variable rate of progression towards biliary
#cirrhosis
. This REVIEW highlights new insights into pathogenesis & potential therapeutic targets
ICYMI | The therapeutic pipeline for
#NASH
is expanding as insights into pathophysiology are gained, this REVIEW summarises progress in the development of NASH therapies, current & ongoing trials, and potential challenges
#NAFLD
#fattyliver
This Figure shows the molecular mechanisms & metabolites produced by the gut
#microbiota
that act on receptors in the intestine or white and brown
#adiposetissue
Find out more in this REVIEW
Cholangiocytes, the epithelial cells lining the intrahepatic and extrahepatic bile ducts, are highly specialized cells. This state-of-the-art REVIEW provides an overview of
#cholangiocyte
pathobiology
Our JANUARY ISSUE is live! Pancreatic cancer therapeutics, CRC epidemiology, early-life gut microbiome, NAFLD cirrhosis recompensation and digital histology, and much more!
This FIGURE shows the circadian regulation of glucose homeostasis. The suprachiasmatic nucleus (SCN) signals via neuroendocrine pathways to the peripheral clocks in pancreas, gut, fat, skeletal muscle and the liver.
Find out more in this REVIEW